As an organization dedicated to improving cardiovascular health, the National Forum is excited that the FDA approved Entresto ™ (sacubitril/valsartan) as it has the potential to reduce heart failure mortality in the U.S.
Million Hearts® Hypertension Control Challenge Champions explain how they improved patients' blood pressure
Million Hearts® named 30 clinicians and their teams Hypertension Challenge Champions in March of 2015. All those awarded this honor achieved blood pressure control for at least 70% of their patients.
LillyPad, an official blog of Eli Lilly and Company, quoted the National Forum's Executive Director John Clymer, on their post about about the 2015 BIO International Convention in Philadelphia, Penn.
Partially hydrogenated oils, also known as Trans fats, have long been an enemy to heart health. Research has shown for some time now that trans fats contribute to cardiovascular disease by raising “bad” cholesterol while simultaneously lowering “good” cholesterol.
Medical Marketing & Media highlighted the National Forum's Executive Director John Clymer's views on patient engagement during the 2015 BiO International Convention in Philadelphia, Penn.
The National Forum is encouraged by the efficacy data from recent PCSK9 inhibitor trials.
New York City could be the first U.S. metropolitan to require warning labels on high-salt dishes at chain restaurants.
The National Forum is excited that new cardiovascular drugs may be available soon to patients who suffer from common forms of heart disease, including heart failure and atherosclerosis.
Of every 100 prescriptions written by a clinician, only about 15 are taken and refilled properly. That low number has a high cost.